PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430070

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430070

Global Hydrocephalus Market - Industry Trends and Forecast to 2031

PUBLISHED: January 1, 2024

PAGES: 272 Pages

DELIVERY TIME: Inquiry

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Global hydrocephalus market is expected to reach USD 2,592,720.77 thousand by 2031 from USD 1,587,759.20 thousand in 2023, growing with a CAGR of 6.5% in the forecast period of 2024 to 2031.

Market Segmentation

Global Hydrocephalus Market, By Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), Diagnostic & Treatment (Diagnosis and Treatment), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.

Overview of Global Hydrocephalus Market Dynamics

Driver
Increasing incidence of neurological conditions
Restraint
Poor reimbursement policies
Opportunity
Growing support by healthcare organizations and government bodies

Market Players

Some of the key market players operating in the global hydrocephalus market are:

Aesculap, Inc. - a B. Braun company
Integra LifeSciences
G.SURGIWEAR LTD
MOLLER Medical GmbH
Anuncia Inc.
CHRISTOPH MIETHKE GMBH & CO. KG
KARL STORZ SE & Co. KG
Proteses, inc.
Medtronic
natus
Desu Medical
Bicakcilar
Spiegelberg GmbH & Co.KG
Sophysa
KANEKA MEDIX CORP

1 INTRODUCTION 32

1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.3 OVERVIEW OF GLOBAL HYDROCEPHALUS MARKET 32
1.4 LIMITATIONS 33
1.5 MARKETS COVERED 33

2 MARKET SEGMENTATION 36

2.1 MARKETS COVERED 36
2.2 GEOGRAPHICAL SCOPE 37
2.3 YEARS CONSIDERED FOR THE STUDY 38
2.4 CURRENCY AND PRICING 38
2.5 DBMR TRIPOD DATA VALIDATION MODEL 39
2.6 MULTIVARIATE MODELLING 42
2.7 TYPE LIFELINE CURVE 42
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 43
2.9 DBMR MARKET POSITION GRID 44
2.10 VENDOR SHARE ANALYSIS 45
2.11 SECONDARY SOURCES 46
2.12 ASSUMPTIONS 46

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 49

5 GLOBAL HYDROCEPHALUS MARKET: REGULATIONS 52

5.1 REGULATIONS IN U.S. 52
5.2 REGULATIONS IN EUROPE 52
5.3 REGULATIONS IN INDIA 52
5.4 REGULATIONS IN JAPAN 53
5.5 REGULATIONS IN BRAZIL 53

6 MARKET OVERVIEW 54

6.1 DRIVERS 56
- 6.1.1 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS 56
- 6.1.2 GROWING NUMBER OF NEW-BORNS AFFECTED BY HYDROCEPHALUS 56
- 6.1.3 INCREASING ADAPTATION OF ADVANCED PROGRAMMABLE VALVES 57
- 6.1.4 RISING AWARENESS ABOUT HYDROCEPHALUS 57
6.2 RESTRAINTS 58
- 6.2.1 POOR REIMBURSEMENT POLICIES 58
- 6.2.2 DELETERIOUS COMPLICATIONS WITH HYDROCEPHALUS DEVICES 58
6.3 OPPORTUNITIES 59
- 6.3.1 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES 59
- 6.3.2 GROWING HEALTHCARE EXPENDITURE 60
- 6.3.3 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 60
6.4 CHALLENGES 61
- 6.4.1 HIGH PRODUCT RECALL SCENARIO 61
- 6.4.2 LACK OF ACCESSIBILITY OF HYDROCEPHALUS PRODUCTS 61

7 GLOBAL HYDROCEPHALUS MARKET, BY TYPE 62

7.1 OVERVIEW 63
7.2 CONGENITAL HYDROCEPHALUS 66
7.3 ACQUIRED HYDROCEPHALUS 66
7.4 NORMAL-PRESSURE HYDROCEPHALUS 67
7.5 EX-VACUO HYDROCEPHALUS 67

8 GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT 68

8.1 OVERVIEW 69
8.2 DIAGNOSTICS 72
- 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 72
- 8.2.2 CT SCAN - HEAD 72
- 8.2.3 HEAD ULTRASOUND 73
8.3 TREATMENT 73
- 8.3.1 SURGERY - SHUNT INSERTION, BY PRODUCT TYPE 74
  - 8.3.1.1 HYDROCEPHALUS VALVES 74
  - 8.3.1.2 HYDROCEPHALUS CATHETERS 74
    - 8.3.1.2.1 ADJUSTABLE PRESSURE VALVES 74
    - 8.3.1.2.2 FIX PRESSURE VALVES 75
- 8.3.2 SURGERY - SHUNT INSERTION, BY AGE GROUP 75
  - 8.3.2.1 PEDIATRIC 75
  - 8.3.2.2 ADULT 75
- 8.3.3 VENTRICULOSTOMY 75
- 8.3.4 MEDICATION 75
- 8.3.5 TREATMENT, BY AGE GROUP 76
- 8.3.6 INFANTS 76
- 8.3.7 CHILDREN 76
- 8.3.8 ADULTS 76

9 GLOBAL HYDROCEPHALUS MARKET, BY END USERS 77

9.1 OVERVIEW 78
9.2 HOSPITALS 81
9.3 CLINICS 81
9.4 DIAGNOSTIC CENTERS 82
9.5 ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS 82
- 9.5.1 HOSPITALS 83
- 9.5.2 AMBULATORY AND SURGICAL CENTERS 83
- 9.5.3 HOSPITALS 83
- 9.5.4 CLINICS 83
- 9.5.5 DIAGNOSTIC CENTER 84
- 9.5.6 SURGICAL CENTERS 84
- 9.5.7 AMBULATORY SURGICAL CENTERS 84
- 9.5.8 OTHERS 84

10 GLOBAL HYDROCEPHALUS MARKET, BY REGION 85

10.1 OVERVIEW 86
10.2 NORTH AMERICA 89
- 10.2.1 U.S. 93
- 10.2.2 CANADA 97
- 10.2.3 MEXICO 101
10.3 EUROPE 105
- 10.3.1 GERMANY 110
- 10.3.2 FRANCE 114
- 10.3.3 U.K. 118
- 10.3.4 ITALY 122
- 10.3.5 SPAIN 126
- 10.3.6 RUSSIA 130
- 10.3.7 TURKEY 134
- 10.3.8 IRELAND 138
- 10.3.9 BELGIUM 142
- 10.3.10 NETHERLANDS 146
- 10.3.11 SWITZERLAND 150
- 10.3.12 REST OF EUROPE 154
10.4 ASIA-PACIFIC 155
- 10.4.1 JAPAN 160
- 10.4.2 CHINA 164
- 10.4.3 SOUTH KOREA 168
- 10.4.4 INDIA 172
- 10.4.5 AUSTRALIA 176
- 10.4.6 SINGAPORE 180
- 10.4.7 THAILAND 184
- 10.4.8 MALAYSIA 188
- 10.4.9 INDONESIA 192
- 10.4.10 PHILIPPINES 196
- 10.4.11 VIETNAM 200
- 10.4.12 REST OF ASIA-PACIFIC 204
10.5 SOUTH AMERICA 205
- 10.5.1 BRAZIL 209
- 10.5.2 ARGENTINA 213
- 10.5.3 REST OF SOUTH AMERICA 217
10.6 MIDDLE EAST AND AFRICA 218
- 10.6.1 SOUTH AFRICA 222
- 10.6.2 SAUDI ARABIA 225
- 10.6.3 U.A.E. 228
- 10.6.4 EGYPT 231
- 10.6.5 ISRAEL 234
- 10.6.6 REST OF MIDDLE EAST & AFRICA 237

11 GLOBAL HYDROCEPHALUS MARKET, COMPANY LANDSCAPE 238

11.1 COMPANY SHARE ANALYSIS: GLOBAL 238
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 239
11.3 COMPANY SHARE ANALYSIS: EUROPE 240
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 241

12 SWOT ANALYSIS 242

13 COMPANY PROFILE 243

13.1 MEDTRONIC 243
- 13.1.1 COMPANY SNAPSHOT 243
- 13.1.2 REVENUE ANALYSIS 243
- 13.1.3 COMPANY SHARE ANALYSIS 244
- 13.1.4 PRODUCT PORTFOLIO 244
- 13.1.5 RECENT DEVELOPMENTS 244
13.2 AESCULAP, INC. - A B. BRAUN COMPANY 245
- 13.2.1 COMPANY SNAPSHOT 245
- 13.2.2 COMPANY SHARE ANALYSIS 245
- 13.2.3 PRODUCT PORTFOLIO 246
- 13.2.4 RECENT DEVELOPMENT 246
13.3 INTEGRA LIFESCIENCES 247
- 13.3.1 COMPANY SNAPSHOT 247
- 13.3.2 REVENUE ANALYSIS 247
- 13.3.3 COMPANY SHARE ANALYSIS 248
- 13.3.4 PRODUCT PORTFOLIO 248
- 13.3.5 RECENT DEVELOPMENT 249
13.4 SPIEGELBERG GMBH & CO. KG 250
- 13.4.1 COMPANY SNAPSHOT 250
- 13.4.2 COMPANY SHARE ANALYSIS 250
- 13.4.3 PRODUCT PORTFOLIO 251
- 13.4.4 RECENT DEVELOPMENT 251
13.5 BICAKCILAR 252
- 13.5.1 COMPANY SNAPSHOT 252
- 13.5.2 COMPANY SHARE ANALYSIS 252
- 13.5.3 PRODUCT PORTFOLIO 253
- 13.5.4 RECENT DEVELOPMENTS 253
13.6 ANUNCIA INC 254
- 13.6.1 COMPANY SNAPSHOT 254
- 13.6.2 PRODUCT PORTFOLIO 254
- 13.6.3 RECENT DEVELOPMENT 254
13.7 CHRISTOPH MIETHKE GMBH & CO. KG 255
- 13.7.1 COMPANY SNAPSHOT 255
- 13.7.2 PRODUCT PORTFOLIO 255
- 13.7.3 RECENT DEVELOPMENT 256
13.8 DESU MEDICAL 257
- 13.8.1 COMPANY SNAPSHOT 257
- 13.8.2 PRODUCT PORTFOLIO 257
- 13.8.3 RECENT DEVELOPMENT 257
13.9 G.SURGIWEAR LTD 258
- 13.9.1 COMPANY SNAPSHOT 258
- 13.9.2 PRODUCT PORTFOLIO 258
- 13.9.3 RECENT DEVELOPMENT 258
13.10 HPBIO 259
- 13.10.1 COMPANY SNAPSHOT 259
- 13.10.2 PRODUCT PORTFOLIO 259
- 13.10.3 RECENT DEVELOPMENT 259
13.11 KANEKA MEDIX CORP 260
- 13.11.1 COMPANY SNAPSHOT 260
- 13.11.2 REVENUE ANALYSIS 260
- 13.11.3 PRODUCT PORTFOLIO 262
- 13.11.4 RECENT DEVELOPMENTS 262
13.12 KARL STORZ SE & CO. KG 263
- 13.12.1 COMPANY SNAPSHOT 263
- 13.12.2 PRODUCT PORTFOLIO 263
- 13.12.3 RECENT DEVELOPMENT 263
13.13 MOLLER MEDICAL GMBH 264
- 13.13.1 COMPANY SNAPSHOT 264
- 13.13.2 PRODUCT PORTFOLIO 264
- 13.13.3 RECENT DEVELOPMENT 264
13.14 NATUS MEDICAL INCORPORATED 265
- 13.14.1 COMPANY SNAPSHOT 265
- 13.14.2 PRODUCT PORTFOLIO 265
- 13.14.3 RECENT DEVELOPMENTS 266
13.15 SOPHYSA 267
- 13.15.1 COMPANY SNAPSHOT 267
- 13.15.2 PRODUCT PORTFOLIO 267
- 13.15.3 RECENT DEVELOPMENTS 268

14 QUESTIONNAIRE 269

15 RELATED REPORTS 272

LIST OF TABLES

TABLE 1 GLOBAL HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 65
TABLE 2 GLOBAL CONGENITAL HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
TABLE 3 GLOBAL ACQUIRED HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
TABLE 4 GLOBAL NORMAL-PRESSURE HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 67
TABLE 5 GLOBAL EX-VACUO HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 67
TABLE 6 GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 71
TABLE 7 GLOBAL DIAGNOSTIC IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD MILLION) 72
TABLE 8 GLOBAL DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 72
TABLE 9 GLOBAL TREATMENT IN HYDROCEPHALUS MARKET, BY REGION, 2019-2028 (USD MILLION) 73
TABLE 10 GLOBAL TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 73
TABLE 11 GLOBAL SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
TABLE 12 GLOBAL HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
TABLE 13 GLOBAL SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 75
TABLE 14 GLOBAL TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 76
TABLE 15 GLOBAL HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 80
TABLE 16 GLOBAL HOSPITALS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 81
TABLE 17 GLOBAL CLINICS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 81
TABLE 18 GLOBAL DIAGNOSTIC CENTERS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 82
TABLE 19 GLOBAL ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 82
TABLE 20 GLOBAL SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 83
TABLE 21 GLOBAL TREATMENT IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 83
TABLE 22 GLOBAL HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 88
TABLE 23 NORTH AMERICA HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 89
TABLE 24 NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 89
TABLE 25 NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 89
TABLE 26 NORTH AMERICA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 90
TABLE 27 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 90
TABLE 28 NORTH AMERICA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 90
TABLE 29 NORTH AMERICA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 91
TABLE 30 NORTH AMERICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 91
TABLE 31 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 91
TABLE 32 NORTH AMERICA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 92
TABLE 33 NORTH AMERICA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 92
TABLE 34 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 92
TABLE 35 U.S. HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 93
TABLE 36 U.S. HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 93
TABLE 37 U.S. DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 93
TABLE 38 U.S. TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 94
TABLE 39 U.S. SURGERY -SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 94
TABLE 40 U.S. HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 94
TABLE 41 U.S. SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 95
TABLE 42 U.S. TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 95
TABLE 43 U.S. HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 95
TABLE 44 U.S. SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 96
TABLE 45 U.S. TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 96
TABLE 46 CANADA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 97
TABLE 47 CANADA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 97
TABLE 48 CANADA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 97
TABLE 49 CANADA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 98
TABLE 50 CANADA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 98
TABLE 51 CANADA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 98
TABLE 52 CANADA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 99
TABLE 53 CANADA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 99
TABLE 54 CANADA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 99
TABLE 55 CANADA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 100
TABLE 56 CANADA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 100
TABLE 57 MEXICO HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 101
TABLE 58 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 101
TABLE 59 MEXICO DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 101
TABLE 60 MEXICO TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 102
TABLE 61 MEXICO HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 102
TABLE 62 MEXICO HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 102
TABLE 63 MEXICO SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 103
TABLE 64 MEXICO TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 103
TABLE 65 MEXICO HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 103
TABLE 66 MEXICO SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 104
TABLE 67 MEXICO TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 104
TABLE 68 EUROPE HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 105
TABLE 69 EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 106
TABLE 70 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 106
TABLE 71 EUROPE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 106
TABLE 72 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 107
TABLE 73 EUROPE HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 107
TABLE 74 EUROPE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 107
TABLE 75 EUROPE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 108
TABLE 76 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 108
TABLE 77 EUROPE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 108
TABLE 78 EUROPE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 109
TABLE 79 EUROPE TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 109
TABLE 80 GERMANY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 110
TABLE 81 GERMANY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 110
TABLE 82 GERMANY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 110
TABLE 83 GERMANY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 111
TABLE 84 GERMANY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 111
TABLE 85 GERMANY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 111
TABLE 86 GERMANY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 112
TABLE 87 GERMANY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 112
TABLE 88 GERMANY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 112
TABLE 89 GERMANY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 113
TABLE 90 GERMANY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 113
TABLE 91 FRANCE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 114
TABLE 92 FRANCE HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 114
TABLE 93 FRANCE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 114
TABLE 94 FRANCE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 115
TABLE 95 FRANCE HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 115
TABLE 96 FRANCE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 115
TABLE 97 FRANCE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 116
TABLE 98 FRANCE TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 116
TABLE 99 FRANCE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 116
TABLE 100 FRANCE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 117
TABLE 101 FRANCE TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 117
TABLE 102 U.K. HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 118
TABLE 103 U.K. HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 118
TABLE 104 U.K. DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 118
TABLE 105 U.K. TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 119
TABLE 106 U.K. HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 119
TABLE 107 U.K. HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 119
TABLE 108 U.K. SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 120
TABLE 109 U.K. TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 120
TABLE 110 U.K. HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 120
TABLE 111 U.K. SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 121
TABLE 112 U.K. TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 121
TABLE 113 ITALY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 122
TABLE 114 ITALY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 122
TABLE 115 ITALY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 122
TABLE 116 ITALY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 123
TABLE 117 ITALY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 123
TABLE 118 ITALY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 123
TABLE 119 ITALY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 124
TABLE 120 ITALY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 124
TABLE 121 ITALY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 124
TABLE 122 ITALY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 125
TABLE 123 ITALY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 125
TABLE 124 SPAIN HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 126
TABLE 125 SPAIN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 126
TABLE 126 SPAIN DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 126
TABLE 127 SPAIN TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 127
TABLE 128 SPAIN HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 127
TABLE 129 SPAIN HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 127
TABLE 130 SPAIN SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 128
TABLE 131 SPAIN TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 128
TABLE 132 SPAIN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 128
TABLE 133 SPAIN SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 129
TABLE 134 SPAIN TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 129
TABLE 135 RUSSIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 130
TABLE 136 RUSSIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 130
TABLE 137 RUSSIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 130
TABLE 138 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 131
TABLE 139 RUSSIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 131
TABLE 140 RUSSIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 131
TABLE 141 RUSSIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 132
TABLE 142 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 132
TABLE 143 RUSSIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 132
TABLE 144 RUSSIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 133
TABLE 145 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 133
TABLE 146 TURKEY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 134
TABLE 147 TURKEY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 134
TABLE 148 TURKEY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 134
TABLE 149 TURKEY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 135
TABLE 150 TURKEY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 135
TABLE 151 TURKEY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 135
TABLE 152 TURKEY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 136
TABLE 153 TURKEY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 136
TABLE 154 TURKEY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 136
TABLE 155 TURKEY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 137
TABLE 156 TURKEY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 137
TABLE 157 IRELAND HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 138
TABLE 158 IRELAND HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 138
TABLE 159 IRELAND DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 138
TABLE 160 IRELAND TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 139
TABLE 161 IRELAND HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 139
TABLE 162 IRELAND HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 139
TABLE 163 IRELAND SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 140
TABLE 164 IRELAND TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 140
TABLE 165 IRELAND HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 140
TABLE 166 IRELAND SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 141
TABLE 167 IRELAND TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 141
TABLE 168 BELGIUM HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 142
TABLE 169 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 142
TABLE 170 BELGIUM DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 142
TABLE 171 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 143
TABLE 172 BELGIUM HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 143
TABLE 173 BELGIUM HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 143
TABLE 174 BELGIUM SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 144
TABLE 175 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 144
TABLE 176 BELGIUM HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 144
TABLE 177 BELGIUM SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 145
TABLE 178 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 145
TABLE 179 NETHERLANDS HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 146
TABLE 180 NETHERLANDS HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 146
TABLE 181 NETHERLANDS DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 146
TABLE 182 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 147
TABLE 183 NETHERLANDS HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 147
TABLE 184 NETHERLANDS HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 147
TABLE 185 NETHERLANDS SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 148
TABLE 186 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 148
TABLE 187 NETHERLANDS HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 148
TABLE 188 NETHERLANDS SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 149
TABLE 189 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 149
TABLE 190 SWITZERLAND HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 150
TABLE 191 SWITZERLAND HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 150
TABLE 192 SWITZERLAND DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 150
TABLE 193 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 151
TABLE 194 SWITZERLAND HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 151
TABLE 195 SWITZERLAND HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 151
TABLE 196 SWITZERLAND SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 152
TABLE 197 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 152
TABLE 198 SWITZERLAND HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 152
TABLE 199 SWITZERLAND SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 153
TABLE 200 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 153
TABLE 201 REST OF EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 154
TABLE 202 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 155
TABLE 203 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 155
TABLE 204 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 156
TABLE 205 ASIA-PACIFIC DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 156
TABLE 206 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 156
TABLE 207 ASIA-PACIFIC HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 157
TABLE 208 ASIA-PACIFIC HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 157
TABLE 209 ASIA-PACIFIC SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 157
TABLE 210 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 158
TABLE 211 ASIA-PACIFIC HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 158
TABLE 212 ASIA-PACIFIC SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 158
TABLE 213 ASIA-PACIFIC TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 159
TABLE 214 JAPAN HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 160
TABLE 215 JAPAN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 160
TABLE 216 JAPAN DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 160
TABLE 217 JAPAN TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 161
TABLE 218 JAPAN HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 161
TABLE 219 JAPAN HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 161
TABLE 220 JAPAN SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 162
TABLE 221 JAPAN TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 162
TABLE 222 JAPAN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 162
TABLE 223 JAPAN SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 163
TABLE 224 JAPAN TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 163
TABLE 225 CHINA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 164
TABLE 226 CHINA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 164
TABLE 227 CHINA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 164
TABLE 228 CHINA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 165
TABLE 229 CHINA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 165
TABLE 230 CHINA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 165
TABLE 231 CHINA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 166
TABLE 232 CHINA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 166
TABLE 233 CHINA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 166
TABLE 234 CHINA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 167

LIST OF FIGURES

FIGURE 1 GLOBAL HYDROCEPHALUS MARKET: SEGMENTATION 36
FIGURE 2 GLOBAL HYDROCEPHALUS MARKET: DATA TRIANGULATION 39
FIGURE 3 GLOBAL HYDROCEPHALUS MARKET: DROC ANALYSIS 40
FIGURE 4 GLOBAL HYDROCEPHALUS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 41
FIGURE 5 GLOBAL HYDROCEPHALUS MARKET: COMPANY RESEARCH ANALYSIS 41
FIGURE 6 GLOBAL HYDROCEPHALUS MARKET: INTERVIEW DEMOGRAPHICS 43
FIGURE 7 GLOBAL HYDROCEPHALUS MARKET: DBMR MARKET POSITION GRID 44
FIGURE 8 GLOBAL HYDROCEPHALUS MARKET: VENDOR SHARE ANALYSIS 45
FIGURE 9 GLOBAL HYDROCEPHALUS MARKET: SEGMENTATION 48
FIGURE 10 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS IS EXPECTED TO DRIVE THE GLOBAL HYDROCEPHALUS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 49
FIGURE 11 CONGENITAL HYDROCEPHALUS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HYDROCEPHALUS MARKET IN 2024 & 2031 49
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL HYDROCEPHALUS MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031 50
FIGURE 13 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR HYDROCEPHALUS MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031 51
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL HYDROCEPHALUS MARKET 55
FIGURE 15 GLOBAL HYDROCEPHALUS MARKET: BY TYPE, 2023 63
FIGURE 16 GLOBAL HYDROCEPHALUS MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 64
FIGURE 17 GLOBAL HYDROCEPHALUS MARKET: BY TYPE, CAGR (2024-2031) 64
FIGURE 18 GLOBAL HYDROCEPHALUS MARKET: BY TYPE, LIFELINE CURVE 65
FIGURE 19 GLOBAL HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2023 69
FIGURE 20 GLOBAL HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2024-2031 (USD THOUSAND) 70
FIGURE 21 GLOBAL HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, CAGR (2024-2031) 70
FIGURE 22 GLOBAL HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, LIFELINE CURVE 71
FIGURE 23 GLOBAL HYDROCEPHALUS MARKET: BY END USERS, 2023 78
FIGURE 24 GLOBAL HYDROCEPHALUS MARKET: BY END USERS, 2024-2031 (USD THOUSAND) 79
FIGURE 25 GLOBAL HYDROCEPHALUS MARKET: BY END USERS, CAGR (2024-2031) 79
FIGURE 26 GLOBAL HYDROCEPHALUS MARKET: BY END USERS, LIFELINE CURVE 80
FIGURE 27 GLOBAL HYDROCEPHALUS MARKET: SNAPSHOT (2023) 87
FIGURE 28 GLOBAL HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 238
FIGURE 29 NORTH AMERICA HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 239
FIGURE 30 EUROPE HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 240
FIGURE 31 ASIA-PACIFIC HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 241

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ